2B0S
Crystal structure analysis of anti-HIV-1 V3 Fab 2219 in complex with MN peptide
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRL BEAMLINE BL9-2 |
Synchrotron site | SSRL |
Beamline | BL9-2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2002-06-15 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 1.033 |
Spacegroup name | P 41 21 2 |
Unit cell lengths | 60.471, 60.471, 275.194 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 69.010 - 2.300 |
R-factor | 0.21926 |
Rwork | 0.217 |
R-free | 0.26665 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 7fab |
RMSD bond length | 0.013 |
RMSD bond angle | 1.458 |
Data reduction software | DENZO |
Data scaling software | SCALEPACK |
Phasing software | AMoRE |
Refinement software | REFMAC (5.2) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 69.010 | 2.340 |
High resolution limit [Å] | 2.300 | 2.300 |
Number of reflections | 23835 | |
<I/σ(I)> | 22 | 3.5 |
Completeness [%] | 99.8 | 100 |
Redundancy | 5.3 | 5.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 298 | 40% PEG 400, 0.2M potassium acetate, VAPOR DIFFUSION, SITTING DROP, temperature 298.0K |